Urelumab (Anti-TNFRSF9 / 4-1BB / CD137)
Products
Description
Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) is a fully human agonistic monoclonal antibody targeting the CD137 receptor with potential immunostimulatory and antineoplastic activities. MW : 146.5 KD.
Specifications
| Manufacturer Cat# | A2321 |
|---|---|
| Target | CD markers |